News

On this International Day of Radiology, we celebrate the transformative power of medical imaging—and the people behind it.

At mediri, we’re committed to making the radiologist’s job easier, faster, and more precise. How? Through customized web-based forms tailored to each clinical study. Whether it’s a screening visit or an inclusion assessment, our tools help radiologists:

• Make faster decisions on patient eligibility
• Communicate results instantly with study sites
• Evaluate visits efficiently and assign patients to the correct study arm

By streamlining workflows and reducing administrative overhead, we empower radiologists to focus on what matters most: delivering high-quality insights that drive better patient outcomes.

Today, we honor the radiology community—and reaffirm our mission to support it with smart, intuitive technology.

Next Sneak Peek: the RANO-HGG Response Assessment.
Continuing our journey through the new mTRIAL release!

Designed with clarity and precision in mind, this report offers a comprehensive overview of:

• SPD analysis (sum of the products of diameters) of target lesions
• Thumbnails of target lesions for visual reference
• Status for non-target lesions
• Response classification based on imaging and clinical parameters
• A dynamic Lesion Progression Chart for longitudinal tracking

This new report brings structure and transparency to complex data, helping clinicians make informed decisions faster and with confidence. We’re proud to take another step toward smarter, more efficient neuro-oncology workflows.

Next up in our mTRIAL release preview:
the Unidirectional Feature for RECIST MRI — a key advancement in longitudinal lesion tracking and precision oncology.

Users can now measure lesion diameters with pinpoint accuracy, activate a second viewing window to compare follow-up exams, and adjust views to assess additional lesions — all within one streamlined workflow. Seamless transitions between examinations make longitudinal analysis faster and more intuitive than ever.

October marks Breast Cancer Awareness Month — a global initiative to promote prevention, early detection, and innovative research against breast cancer.

We’re proud to contribute to this mission through our involvement in the Marie-Skłodowska-Curie network BosomShield. Together, we’re advancing breast cancer treatment by integrating clinical, pathological, and radiological data.

Our PhD researchers are developing AI-driven methods for lesion segmentation and classification across multiple imaging modalities — aiming to improve relapse probability prediction and support more personalized care.

Let’s keep pushing boundaries in research and raising awareness.

Next up in our mTRIAL release preview: the Spline Feature for RECIST CT — a game-changer in lesion annotation and precision oncology.

Users can now outline target lesions point by point, creating smooth, adaptive contours for complex shapes. With additional viewing windows, it’s easy to compare multiple studies side by side — unlocking deeper clinical insights.
More innovations coming soon!

This week, we introduce the Tridirectional Feature — empowering users to angulate in three dimensions and measure tumor size across three orthogonal directions with precision and ease.
A powerful step forward in volumetric analysis and clinical insight.

Stay tuned — more innovations are on the horizon!

Hot of the press results from out partner Quantified Imaging prove the potential of ASL MRI for dementia research.
We offer powerful imaging methods and analysis to support treatment response evaluation in clinical trials for Alzheimer’s disease.

– ASL MRI shows strong correlation between perfusion change and cognitive improvement under Lecanemab therapy — outperforming volume-based metrics.
– Baseline prediction highlights ASL’s potential to identify responders before treatment begins.

A non-invasive, cost-effective alternative to PET — ideal for clinical trials and routine care.

Next Sneak Peek: The Freehand Feature.
Continuing our journey through the new mTRIAL release!

After showcasing the precision of the Spline tool, we now present the Freehand Feature — designed for intuitive and flexible lesion outlining.

More exciting features are just around the corner — stay connected! 

Third Sneak Peek: The Spline Feature
Another exciting reveal from the upcoming mTRIAL release!

Following the Lifewire tool, we’re thrilled to introduce Spline — a precision-driven feature that allows users to draw lesion outlines point by point. This manual approach gives full control over the shape and detail of the region of interest, making it ideal for complex or irregular lesions that require expert-level accuracy.

Whether you’re refining segmentation or preparing data for analysis, Spline empowers you to work with confidence and clarity.

Stay tuned — more innovations are on the way to transform your imaging workflow!

We’re back with another exciting feature from our upcoming mTRIAL release.

Second Sneak Peek: The Livewire Feature
This powerful tool enables users to draw lesion outlines with threshold-based segmentation support, making it easier than ever to define and analyze regions of interest in medical imaging.

This is just one of many innovations coming your way — stay tuned for more features that will elevate your imaging experience!